$23 billion under management
New Enterprise Associates is an American venture capital firm that was founded in 1977 by C. Richard Kramlich, Chuck Newhall, and Frank Bonsal. The company headquarter is in Menlo Park, California. Along with it, the firm has offices in 8 other cities – San-Francisco, New York City, Boston, Baltimore, Mumbai, Bangalore, Beijing, Shanghai.
New Enterprise Associates was founded by three men who previously worked in the sphere of investments. C. Richard Kramlich worked with venture capitalist Arthur Rock. Frank Bosnal worked as an investment banker at Alex.Brown & Sons. Chuck Newhall managed an investment fund for T. Rowe Price.
Considering the first investment fund, it was managed to raise only $16 million. Whereas the second fund was more than twice successful and raised approximately $45 million. While the sum of the third fund in 1984 was $125 million. The tenth fund reached $2.3 billion in 2000.
The first notable investment made by the company was 3Com in 1981 along with Mayfield Fund and Jack Melchor. The first biopharma investment was in Bethesda Research Labs in 1982. Then they invested in the first gene therapy company in 1987. Nowadays the number of investments made by New Enterprise Associates is close to 2000, and in total 18 funds have been raised. New Enterprise Investments also invested in Microsoft, Didi Chuxing, Vertex Pharmaceuticals, Uber, Woebot Health, Shape Therapeutics.
The portfolio analysis shows that the top 3 countries where the company invests include the USA, India, China. Then Canada, the United Kingdom, and Germany go. Participating in different investments rounds, the firm mostly focuses on the health industry, then – enterprise software, media, and marketing. Most of all the company participates in Series B, Series C, and Series C rounds.